Aerometrex (ASX:AMX) Gains After FY26 Earnings Guidance Moves Higher

Aditi Sarkar

06 August 2026 07:44 PM AEST

Aerometrex (ASX:AMX) Gains After FY26 Earnings Guidance Moves Higher

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

Aerometrex shares closed at AUD 0.285 on 6 August 2026, gaining 11.77%, with market capitalisation near AUD 27.07mn.
Aerometrex upgraded FY26 EBITDA guidance to AUD 7.
The one-year share-price return is 32.56%, placing the latest rise within a markedly different longer-term trend.
The next checkpoints include audited FY26 results, MetroMap renewal rates, cash conversion, contract delivery and the durability of demand from AI customers.

Aerometrex Limited (ASX:AMX) drew fresh market attention after closing at AUD 0.285 on 6 August 2026, up 11.77% for the session. The rise refocused attention on its MetroMap subscription platform and aerial-imagery operations and the company’s most recent operational or corporate filing. With a market capitalisation of approximately AUD 27.07mn, the percentage move was significant relative to the company’s size.

The one-year return stands at 32.56%. That record matters because a sharp daily gain does not by itself resolve the technical, commercial or funding questions surrounding the business. The durability of the move will depend on whether upcoming results support the expectations now reflected in the share price.

Company Overview

Aerometrex Limited operates in aerial mapping and spatial-data services. Its present focus is its MetroMap subscription platform and aerial-imagery operations. Value creation depends on converting current programmes into measurable milestones, maintaining adequate funding and demonstrating that the underlying opportunity can progress beyond early technical or commercial work.

For a company at this stage, announcement quality is often more important than announcement frequency. Results need to establish scale, continuity, economics or customer traction, depending on the business model. Management must also balance near-term activity with the cash required to reach later milestones.

Latest Company Development

Aerometrex upgraded FY26 EBITDA guidance to AUD 7.5–8.0mn, representing growth of approximately 117–132%. MetroMap annual contract value increased 37.8% to AUD 14.55mn. The company has also secured aerial-imagery contracts with government customers and off-the-shelf data agreements involving AI innovators, broadening the commercial use of its imagery library.

The update gives the market a new reference point, but the next filing will need to show how the programme is translating into operational progress. Timetables, expenditure and measurable outcomes will be important because small companies can experience substantial re-rating before the underlying work is complete.

Share Price and Market Snapshot

AMX closed at AUD 0.285 on 6 August 2026, gaining 11.77% for the day. At that price, Aerometrex carried a market capitalisation of approximately AUD 27.07mn. The one-year change was 32.56%, showing that the latest advance occurred within a broader performance pattern that may differ materially from a single session.

The size of the daily move may also reflect liquidity. In smaller ASX companies, limited depth on either side of the order book can magnify percentage changes. Follow-through trading and the response to the next formal announcement should provide more context than the headline gain alone.

What May Shape the Next Move

Attention is likely to centre on audited FY26 results, MetroMap renewal rates, cash conversion, contract delivery and the durability of demand from AI customers. These milestones should help the market assess whether the latest enthusiasm is being supported by improving fundamentals or remains primarily a short-term price response.

Funding is another central consideration. Exploration, product development, market expansion and operational restructuring can all consume cash before producing dependable returns. The next balance-sheet update will therefore matter alongside technical results, customer metrics or production data.

Risks

Government work can be lumpy, flying conditions can delay capture and subscription growth may not translate fully into cash earnings.
The share-price gain may reverse if expectations move ahead of operational evidence.
Future work may be delayed by approvals, contractors, technical problems or market conditions.
Additional funding could increase debt or dilute existing shareholders.
Low liquidity may amplify both upward and downward price movements.

FAQs

Q: Why did Aerometrex shares attract attention?

A: AMX closed at AUD 0.285, gaining 11.77% and lifting the company’s market capitalisation to approximately AUD 27.07mn.

Q: What is the latest development at Aerometrex?

A: Aerometrex upgraded FY26 EBITDA guidance to AUD 7.5–8.0mn, representing growth of approximately 117–132%. MetroMap annual contract value increased 37.8% to AUD 14.55mn. The company has also secured aerial-imagery contracts with government customers and off-the-shelf data agreements involving AI innovators, broadening the commercial use of its imagery library.

Q: How has AMX performed over one year?

A: The shares recorded a one-year change of 32.56% at the stated market date.

Q: What should shareholders watch next?

A: The main checkpoints are audited FY26 results, MetroMap renewal rates, cash conversion, contract delivery and the durability of demand from AI customers.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.